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Abstract Locus control regions (LCRs) are cis-acting elements 
that confer position-independent and copy-nnmber-dependent 
expression upon associated genes in transgenic mice. Here we 
show the second example of the use of an LCR (the rat LAP 
LCR) in a stable expression vector system, used here in 
conjunction with the rat liver (NRLM) cell line. Non-transfected 
NRLM cells are electrically silent and highly suitable for patch 
clump electrophysiology. We report reliable constitutive xpres- 
sion from two different K + channel cDNAs; the voltage-gated rat 
clone Kv3.4 and the inward rectifier mouse clone Kir2.1. We 
further show that constitutive xpression levels are stable for at 
least 8 weeks from initial recording. 
Key words: Locus control region; Liver activating protein; 
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1. Introduction 
Locus control regions (LCRs) are cis-acting elements that 
confer position-independent expression upon their associated 
genes and gene clusters in the genome. LCRs are further 
characterised by the presence of nuclease-sensitive domains. 
For example, the extensively characterised LCR of the human 
I]-globin gene cluster is delineated by a group of four nucle- 
ase-sensitive domains located upstream of the cluster [1-3]. 
These domains are rich in transcription factor binding sites, 
and a possible role of the LCR is to keep associated promot- 
ers free of histones and allow transcription initiation to occur 
unimpeded [4]. 
Presently, only one eukaryotic expression vector system em- 
ploying LCR sequences has been reported. This, the LCR/  
MEL system [5], uses sequences from the human [5-globin 
LCR upstream of a [3-globin gene backbone where heterolo- 
gous cDNAs can be inserted in the expression vector. Follow- 
ing stable transfection into mouse erythroleukaemia (MEL) 
cells and subsequent induction to differentiation, high levels 
of heterologous protein can be produced. The system has been 
routinely used in our laboratory for the stable and functional 
expression of K + channel cDNAs and genes [6-8]. 
Recently, a novel LCR has been identified upstream of the 
rat gene coding for the liver-enriched transcriptional ctivator 
protein (LAP) [9], which binds to albumin D promoter ele- 
ments [10]. This 2.8 kb region has been used to direct posi- 
tion-independent and copy number dependent expression in 
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transgenic mouse livers [9]. LAP mRNA has also shown to 
accumulate at high levels in lung, less in spleen and kidney 
and at much lower levels in testis and brain [9]. 
To try to meet the need for a high-level, constitutive, stable 
expression system for ion channels to allow easier coordina- 
tion of expression and analysis by electrophysiology, we have 
taken the 2.8 kb LAP LCR region along with the LAP pro- 
moter and employed them in a novel expression vector. In the 
following report we describe stable, high-level, constitutive 
expression of K + channels in a rat liver epithelial cell line 
under control of the LAP LCR and promoter. 
2. Materials and methods 
2.1. Production of the LAP expression vector pCLAPE6 and Kir2.1 
and Kv3. 4 expression constructs 
Construction of the LAP LCR expression vector pCLAPE6 was 
based upon sequences from the vector pCDNA3 (Invitrogen) and 
LAP LCR and promoter sequences from the construct S1LAP (a 
gift from Prof. U. Schibler, Geneva, Switzerland). Fig. 1 shows the 
construction of pCLAPE6 (see also Table 1). 
Two K + channel expression constructs were made. The inward 
rectifier mIRK1 (Kir2.1) coding sequence [11] was isolated on an 
EcoRI-XhoI fragment from a PCR derived clone [7] and cloned be- 
tween the same sites of pCLAPE6 (Fig. 2). The rat Raw3 (Kv3.4) 
voltage-gated channel cDNA [12] (a kind gift from Prof. Olaf Pongs, 
Hamburg, Germany) was isolated on an Asp718-NotI fragment and 
cloned between the same sites of pCLAPE6. 
Adherent normal rat liver epithelial (NRLM) cells were a gift from 
Dr. T. Gant (Leicester, UK). The NRLM cell line was established 
from a 10-day-old male Fischer (F344) rat [13]. 
2.2. Tissue culture and transfections 
NRLM cells were grown in Williams E medium (Gibco BRL) sup- 
plemented with 10% fetal calf serum and GlutamaxI (Gibco BRL) 
and resuspended by the addition of 0.2 g/1 EDTA in PBS prior to 
transfection. Expression constructs were linearised with ScaI and 
transfected by electroporation as described previously [6] with the 
following changes. Firstly, following electroporation, cells were di- 
luted in fresh culture medium to 1 × 103-1 × 104/ml; secondly, G418 
(0.8 mg/ml) was used for selection; and thirdly, adherent colonies 
were isolated using cloning cylinders (Sigma) and EDTA (0.2 g/l) in 
PBS. Individual colonies were grown on and finally resuspended with 
EDTA to detach and dissociate individual NRLM cells prior to their 
use for recording. 
2.3. Electrophysiological recordings and data analysis 
Whole-cell currents were recorded using an Axopatch 200 A ampli- 
fier. Current records in response to voltage steps were filtered at 5 kHz 
(-3 dB, 8-pole Bessel), digitized at 10 kHz using a TL-1 Labmaster 
interface (Axon Instruments), and analysed on a 486 computer. A 
suite of programs developed using the AxoBASIC library [14] was 
used both to apply voltage clamp command potentials and for ana- 
lysis of whole-cell currents. Patch pipettes were pulled from thin- 
walled borosilicate tubing (o.d. 1.5 mm; Clarke Electromedical, 
UK) and fire polished. Their resistance when filled with pipette solu- 
tion was in the range 5-10 MgL The pipette-filling (intracellular) solu- 
tion contained (mM): KC1, 140; MgCI2, 1; EGTA, 10; HEPES, 10; 
pH adjusted to 7.2 at 22°C. Extracellular solutions contained (mM): 
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KCI, 70 or 5; NaC1, 70 or 135; CaC12, 2; MgC12, 2; HEPES 10; pH 
adjusted to 7.3 at 22°C. 
Analogue means were used to cancel capacity transients as far as 
possible. Series resistance (Rs) was 11.2 + 1.0 Mf~ (n = 40). Up to 80% 
compensation for series resistance was used. Experiments were per- 
formed at room temperature 18-25°C. 
3, Results 
Owing to the high levels of LAP mRNA accumulation i
liver, initial experiments were performed to characterise the 
suitability of a number of liver cell lines for patch clamp 
studies. The NRLM cell line was chosen for transfection ex- 
periments owing to the absence of any observed large native 
voltage-activated currents (Fig. 3A). The NRLM cells used in 
this study had a mean membrane capacitance of 21.4 + 1.8 pF 
(n = 40). Fig. 3 shows the results obtained after transfecting 
NRLM cells with the pCLAPE6/Kir2.1 expression construct. 
3.1. Functional expression of  Kir2.1 
Membrane currents were recorded from single NRLM cells 
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Fig. 1. Production of pCLAPE6, pCDNA3 was cut with BgllI and 
HindlII to remove the CMV enhancer and promoter sequences and 
these two sites filled in and religated to give pCLAPE2. Next, an 
Asp718-SstlI fragment containing the full LAP LCR and main pro- 
moter sequences was ligated into the Asp718 and XhoI sites of 
pCLAPE2 to give pCLAPE4. The Asp718 site of pCLAPE4 was 
then removed by digestion with Asp718, filling in and religation to 
give pCLAPE5. Finally, 131 bp of missing 3' promoter sequence (to 
position -40 to the ATG start codon) and a set of unique restric- 
tion sites were introduced on a set of 11 overlapping oligonucleo- 
tides (Table 1) of which the internal ones were 5' phosphorylated; 
all were annealed and then ligated between the SstlI and XhoI sites 
of pCLAPE5 to give pCLAPE6 (Fig. 2). 
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Fig. 2. pCLAPE6. The main features of pCLAPE6 are the LAP 
LCR and promoter sequences, ampicillin resistance gene (Amp.), 
neomycin resistance gene (Neor), fl origin of replication (fl ori), bo- 
vine growth hormone polyA signal (BGH pA) and unique restric- 
tion enzyme sites for inserting heterologous cDNAs (EcoRI, 
HindlII, NotI, HpaI, Asp718 and XhoI) and the unique ScaI site for 
linearising expression constructs prior to transfection. 
using the conventional whole cell clamp technique and in 
response to voltage steps from a holding potential of -17  
mV (the K + equilibrium potential, EK) to test potentials rang- 
ing between -120  and +60 mV, in 10 mV increments. The 
extracellular and intracellular K + concentrations were 70 and 
140 mM respectively. Under these conditions, no significant 
whole cell currents were detected in non-transfected cells (Fig. 
3A). In contrast, substantial inward currents were recorded 
from transfected NRLM cells at membrane potentials nega- 
tive to EK, while much smaller outward currents were re- 
corded at potentials positive to EK (Fig. 3B). This is consistent 
with the expression of the Kir2,1 gene to produce a homote- 
trameric Kir2.1 channel [7,15]. The current-voltage r lation 
for this cell is illustrated in Fig. 3C, and shows pronounced 
inward rectification. The current amplitudes shown in Fig. 3C 
were divided by the K ÷ driving force to obtain the chord 
conductance (gK=I/(V--EK)). The normalized conductance- 
voltage relation is shown in Fig. 3D and can be fit with a 
Boltzmann equation of the form: 
gK/gK(max) = {1 + exp[-(V-V0.5)/k]} -1 
where V0.5 gives the voltage at which gK/gK(m~) is 0.5, and k 
(mV) is a steepness factor indicating the voltage change for an 
e-fold increase in conductance, at very low conductance. 
Mean values for V0.~ and k were found to be -31 .9+0.8  
mV and 10.1 +0.6 mV (n= 10) respectively. These values are 
similar with a V0.5 value of -26  mV and a k of -10.4  mV 
found for wild-type Kir2.1 channels tably expressed in MEL 
cells [7]. 
3.2. High levels of expression 
A large fraction of any given colony of transfected cells 
expressed inwardly rectifying whole cell currents. For exam- 
284 P.A. Shelton, C. Dart/FEBS Letters 391 (1996) 282-286 
A.  C .  
lnA ] 
20ms 
Voltage (mY) 
-120 -80 -40 ~ 40 8O 
10 g 
-2.0 ~ 
-3.0 (~ 
-4.0 
a .  
lnA [ 
\ 
k . . 
D. 
[10 ~ 
0.6 
~ 0.4 i 
20ms -120 -80 -40 0 40 80 
Voltage (rnV) 
Fig. 3. Expression of Kit2.1 in NRLM cells. Whole-cell currents re- 
corded from non-transfected NRLM cells (A) and NRLM cells 
transfected with the pCLAPE6/Kir 2.1 expression construct (B) in 
response to voltage steps from a holding potential of -17 mV (EK) 
to test potentials from --120 to +60 mV in 10 mV increments. Ex- 
tracellular and intracellular K + concentrations were 70 and 140 mM 
respectively. C: Current voltage relation for cell shown in B. D: 
Voltage dependence of the normalised conductance for cell shown 
in B, data points (filled circles) fitted with a Boltzmann equation 
(solid line). V0.5 value=-33.1 mV, k value= 10.6 mV. 
ple, in one colony, out of nine cells from which whole cell 
currents were recorded, eight gave inwardly rectifying cur- 
rents. The amplitude of the inward currents, measured at 
-100 mV, ranged from 0.25 to 3.5 nA with a mean of 
1.6 + 0.4 nA (n = 8). This value corresponds to a current den- 
sity of 76.3 + 16.2 pA/pF. Furthermore, high fractions of col- 
onies expressing Kir2.1 were seen in seven separate G418 re- 
sistant Kir2.1 expressing cell lines (Fig. 4). 
3.3. Functional expression of voltage-activated Kv3.4 K + 
channels 
To investigate further the viability of the LAP LCR expres- 
sion system, NRLM cells were stably transfected with a 
pCLAPE6/Kv3.4 expression construct. Non-transfected 
NRLM cells again displayed no voltage-activated currents in 
response to a 100 ms voltage step from a holding potential of 
-80  mV to potentials between -60  and +60 mV (Fig. 5A). In 
transfected cells, transient outward currents were evoked 
when the membrane potential was stepped positive to -30 
mV (Fig. 5B). The activated current decayed rapidly during 
the 100 ms depolarizing pulse as expected for the A-type 
Kv3.4 channel. The current-voltage r lation for Kv3.4 is 
shown in Fig. 5C. 
Fig. 5D (filled circles) shows the voltage dependence of the 
normalized peak conductance. The data points can be fit with 
a single Boltzmann equation to obtain the voltage of the half- 
maximal activation, V0.5 and the steepness factor, k. For six 
cells, the mean value of V0.5 was found to be 14.8 + 1.5 mV, 
and the mean value for k, 10.9 + 0.3 mV. Expression of Kv3.4 
cRNA in Xenopus laevis oocytes produces A-type K + chan- 
nels with a V0.~ of 14 mV and a k value of 9.7 mV [12]. The 
voltage dependence of inactivation is also shown in Fig. 5D 
(open circles). This relationship was determined by stepping to 
+30 mV from different holding potentials, ranging from -100 
to +20 mV in 10 mV increments. The results are plotted as the 
fraction of the current elicited by stepping from a holding 
potential of -100 mV. The results were fitted with a single 
Boltzmann from which the value for half-inactivation was 
found to be -26.7+2.7 mV, with a steepness factor of 
-12.6+ 1.2 mV (n=4). Kv3.4 channels expressed in Xenopus 
laevis oocytes have been shown to half inactivate at -29.7 
mV, with a steepness factor of 12.2 mV [12]. 
The time constants of inactivation varied considerably from 
cell to cell. The fastest decay measured at +50 mV was 18 ms, 
and the slowest 227 ms. This wide scatter tends to be a char- 
acteristic feature of cloned A-type K + channels [12,16,17] and 
may occur as a direct consequence of the regulation of fast 
inactivation by cysteine oxidation [17]. Consistent with this, 
we found that the inclusion of reducing agents uch as dithio- 
threitol (10 mM) or reduced glutathione (10 mM) in the patch 
pipette restored fast inactivation to the majority of cells (data 
not shown). 
The potential for long-term expression was also investigated 
using single Kir2.1 and Kv3.4 G418-resistant expressing lines. 
We have observed continual high levels of whole-cell Kir2.1 
and Kv3.4 currents from these clonal lines for 8 weeks (ap- 
proximately 66 passages) following initial colony isolation. 
4. Discussion 
This paper reports the first example of the use of an LCR 
for constitutive expression of functional K + channel cDNAs. 
We have demonstrated the expression of members of two 
different classes of K + channel, the inward rectifier type 
Kir2.1 and the transient A-type Kv3.4, both displaying similar 
Table 1 
Sequences of the 11 overlapping oligonucleotides encoding 131 base pairs of the 3' LAP promoter sequence and new unique restriction enzyme 
sites 
Oligonucleotide Sequence 5'-3' 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
GGCCGGGCAATGACGCGCACCGACCCGGCGGCG 
GGGCGGCGGGAGGGGCCCCGGCGTGACGCAGCC 
CGTTGCCAGGCGCCGCCTTATAAACCTCCGCTC 
GGCCGCCGCCGAGCCGAGTCCGAGCCGCGCAG 
AATTCCGCCCAAGCTTGGGCGGCCGCGTTAACGGGGTACCCCC 
CGTCATTGCCCGGCCGC 
CCCCTCCCGCCGCCCCGCCGCCGGGTCGGTGCG 
CGGCGCCTGGCAACGGGCTGCGTCACGCCGGGG 
GCTCGGCGGCGGCCGAGCGGAGGTTTATAAGG 
AAGCTTGGGCGGAATTCTGCGCGGCTCGGACTCG 
TCGAGGGGGTACCCCGTTAACGCGGCCGCC 
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biophysical properties to those reported following expression 
in Xenopus oocytes. 
One of the main advantages of using LCRs in expression 
vectors is in overcoming the problems of integration site 'po- 
sition effects' for stable expression. In the absence of an LCR, 
the chromatin integration site of an expression construct will 
have a dramatic effect on the level of transcription of the 
associated eDNA or gene [18]. LCRs overcome these position 
effects and provide a powerful tool for the guaranteed high 
level expression of stably integrated expression constructs. 
Analysis of whole cell currents from single cells of seven 
pCLAPE6-Kir2.1, G418-resistant, stably transfected colonies 
showed high numbers of functional channels in most of the 
analysed cells (Fig. 4). This observation supports the position 
independent function of the LCR. 
Another strong feature of this expression strategy is the 
constitutive nature of the expression. We have shown that 
expression levels are high from initial G418 selection and 
have observed continual high levels of expression from a 
high fraction of cells from one pCLAPE6/Kv3.4 and one 
pCLAPE6/Kir2.1 cell line for at least 8 weeks with continual 
culture. For long-term analysis and expression protocols, cells 
can be easily harvested for liquid nitrogen storage at an early 
passage stage, and fresh low passage cell aliquots thawed at 
regular intervals. The constitutive nature of expression has 
also allowed us to propagate a large number of NRLM cell 
lines harbouring different K + channel constructs with much 
easier coordination for patch clamp analysis. This contrasts 
with the need for an induction step before analysis can be 
performed in the LCR/MEL system. 
The [3-globin LCR in the LCR/MEL system is already 
being used for the expression of a wide range of proteins, 
including ion-channels and such proteins as type I and II 
tumor necrosis factor receptors [19] and human calcitonin 
~0 
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Fig. 4. High levels of expression. Bar chart showing the levels of ex- 
pression of Kir2.1 across even G418-resistant colonies. Number of 
cells from each colony for which whole cell recordings were made is 
shown by the total height of each bar, the number of cells from this 
total expressing Kit2.1 (> 100pA inward current at -100 mV) is 
shown by the shaded area. 
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Fig. 5. Expression of Kv3.4 in NRLM cells. Whole-cell currents re- 
corded from (A) non-transfected NRLM cells and (B) NRLM cells 
transfected with the pCLAPE6/Kv3.4 expression construct in re- 
sponse to 100 ms depolarising voltage steps from a holding poten- 
tial of -80 mV to potentials between -60 and +60 mV. Extracellu- 
lar and intracellular K + concentrations were 5 and 140 mM 
respectively. C: Current-voltage r lation for cell shown in B. D: 
Voltage dependence of conductance (filled circles) and steady-state 
inactivation (open circles). The data points have been fitted with 
single Boltzrnann equations to give values of V0.5 = -30 mV and 
k = 11 mV for the inactivation curve. 
receptors [20]. Therefore, the use of the LAP LCR based ex- 
pression system reported here opens up the possibility for the 
functional and high level expression of other proteins. 
The LAP expression system may permit expression in cell 
lines derived from other tissues than liver due to the identifi- 
cation of LAP mRNA in lung, spleen, kidney, testis and 
brain, expression in cell lines derived from these tissues may 
be possible. 
The use of the LAP LCR for the high level constitutive 
expression of K + channel cDNAs shows progress in heterol- 
ogous expression technology. The use of a simple plasmid 
vector for inserting cDNAs and a simple transfection protocol 
into NRLM cells provides a route to reliable, high level con- 
stitutive xpression. 
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